Literature DB >> 24744086

Kawasaki disease: pathophysiology, clinical manifestations, and management.

Victoria R Dimitriades1, Amanda G Brown, Abraham Gedalia.   

Abstract

Kawasaki Disease, a systemic vasculitis of unknown origin with specific predilection for the coronary arteries, is the most common cause of childhood-acquired heart disease in western countries. Despite its world-wide incidence, the pathophysiology of this enigmatic disease is still under investigation. Diagnosis is made on a clinical basis, with supportive laboratory evidence and imaging. Once identified, timely initiation of treatment is imperative in order to quell the inflammatory response and decrease the incidence of long-term sequelae, specifically coronary artery aneurysms. Finally, longitudinal follow-up should be implemented based on risk stratification and individualized to each patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24744086     DOI: 10.1007/s11926-014-0423-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  50 in total

1.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors:  Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal:  Nat Genet       Date:  2011-11-13       Impact factor: 38.330

2.  Management of Kawasaki disease: corticosteroids revisited.

Authors:  Mary Beth F Son; Jane W Newburger
Journal:  Lancet       Date:  2012-03-08       Impact factor: 79.321

3.  Parents with a history of Kawasaki disease whose child also had the same disease.

Authors:  Ritei Uehara; Mayumi Yashiro; Yosikazu Nakamura; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2011-08       Impact factor: 1.524

4.  Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.

Authors:  Mary Beth F Son; Kimberlee Gauvreau; Lin Ma; Annette L Baker; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 5.  Kawasaki disease: update on pathogenesis.

Authors:  Rae S M Yeung
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

6.  Etanercept as adjunctive treatment for acute Kawasaki disease: study design and rationale.

Authors:  Michael A Portman; Aaron Olson; Brian Soriano; Nagib Dahdah; Richard Williams; Edward Kirkpatrick
Journal:  Am Heart J       Date:  2011-03       Impact factor: 4.749

7.  Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Authors:  Adriana H Tremoulet; Sonia Jain; Preeti Jaggi; Susan Jimenez-Fernandez; Joan M Pancheri; Xiaoying Sun; John T Kanegaye; John P Kovalchin; Beth F Printz; Octavio Ramilo; Jane C Burns
Journal:  Lancet       Date:  2014-02-24       Impact factor: 79.321

Review 8.  Advances in the treatment of Kawasaki disease.

Authors:  Samuel R Dominguez; Marsha S Anderson
Journal:  Curr Opin Pediatr       Date:  2013-02       Impact factor: 2.856

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

Review 10.  Kawasaki disease: 40 years after the original report.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

View more
  18 in total

Review 1.  Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.

Authors:  Seyyedeh Saneeymehri; Katherine Baker; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

2.  Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.

Authors:  Hua Zhu; Shao-Fei Yu; Yu-Xin Bai; Yan-Yan Liang; Xue-Wen Su; Jing-Ying Pan
Journal:  Exp Ther Med       Date:  2015-05-11       Impact factor: 2.447

3.  Giant right coronary artery aneurysm secondary to Kawasaki disease in child: a case report.

Authors:  Shanshan Zhang; Geli Liu; Tielian Yu; Guiming Zhou; Rongxiu Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 4.  The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.

Authors:  Xiaochuan Xie; Xiaohan Shi; Meilin Liu
Journal:  Pediatr Cardiol       Date:  2017-11-02       Impact factor: 1.655

Review 5.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

6.  Atypical desquamation in a 2.5-year-old boy with Kawasaki disease: A case report.

Authors:  Ali Adib; Ali Fazel; Seyed Hesamedin Nabavizadeh; Sohaila Alyasin; Sara Kashef
Journal:  Electron Physician       Date:  2017-02-25

7.  Salvage of diagnostic quality of image acquired by low-radiation-dose prospectively ECG-triggered coronary CTA during ventricular trigeminy: A case report of a novel image processing method.

Authors:  Harshna V Vadvala; Karl Sayegh; Matthew Moy; Pedro Vinícius Staziaki; Brian B Ghoshhajra
Journal:  HeartRhythm Case Rep       Date:  2015-09-15

8.  Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.

Authors:  Lucy Guile; Simon Parke; Alison Kelly; Robert Tulloh
Journal:  BMJ Case Rep       Date:  2018-03-28

9.  Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.

Authors:  Hyejin Jang; Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

Review 10.  Congenital left ventricular aneurysms and diverticula: an entity in search of an identity.

Authors:  Marc-Alexander Ohlow
Journal:  J Geriatr Cardiol       Date:  2017-12       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.